While HIV continues to impact certain racial and ethnic minorities, the mortality rate in the US continues to drop.
HIV continues to have a disproportionate impact on certain populations, particularly racial and ethnic minorities, gay and bisexual men and other men who have sex with men and transgender women, the Kaiser Family Foundation said in its report, The HIV/AIDS Epidemic in the United States: The Basics.
Black/African American and Hispanic/Latino communities are disproportionately affected by HIV compared to other racial/ethnic groups, HIV.gov reports. Blacks/African Americans represented 13% of the US population, but 41% of people with HIV in 2018, while Hispanics/Latinos represented 18% of the population and 23% of people with HIV.
HIV-related mortality rates have declined significantly since 1995, KFF found. The age-adjusted HIV death rate has dropped by more than 80% since its peak and by almost 50% since 2010.
“This is largely due to ART [antiretroviral therapy], but also to decreasing HIV incidence,” KFF said.
From 2010-2018, death rates decreased by 36.6% overall, Morbidity and Mortality Weekly Report found.
“Early diagnosis, prompt treatment, and maintaining access to high-quality care and treatment have been successful in reducing HIV-related deaths and remain necessary for continuing reductions in HIV-related deaths,” the Centers for Disease Control researchers wrote in MMWR.
Still, more than 5,000 people died with HIV/AIDS as the underlying cause of death in 2019, KFF said.
In addition, while HIV is not a leading cause of death for Americans overall, it remains a leading cause of death for certain age groups. In 2019, HIV was the ninth leading cause of death for those ages 25 to 34, and the tenth for those ages 35-44, KFF found.
Most (66%) newly diagnosed cases of HIV occurred through male-to-male sexual contact, according to KFF, while 4% of diagnoses occurred among gay and bisexual men with a history of injection drug use. However, diagnoses attributable to injection drug use alone have declined significantly over time and accounted for 7% of new diagnoses in 2019.
In other positive news, the number of new HIV infections declined 73% between 1984 and 2019 and 9% between 2015 and 2019. Still, 34,800 people were newly infected with HIV in the U.S. in 2019, and declines were not seen among all populations, KFF found.
While US HIV treatment guidelines recommend initiating ART as soon as patient are diagnosed with HIV, only 66% of those diagnosed receive medical care, according to the CDC, and fewer (57%) are virally suppressed, KFF said.
Get the latest industry news, event updates, and more from Managed healthcare Executive.
A Conversation with Jeremiah Johnson, Executive Director of PrEP4All
August 5th 2025Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the importance of preexposure anaphylaxis and why he’s hesitant to jump on the Lenacapavir breakthrough bandwagon.
Read More
Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent
August 5th 2025Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be available to the people who would benefit most from HIV PrEP?
Read More
Specialty Pharmacy Model Improves HIV Treatment Outcomes in Young Patients
August 5th 2025A new study found that implementing a specialty pharmacy program at St. Jude Children’s Research Hospital helped more young HIV patients achieve medication adherence and undetectable viral loads.
Read More